Display Settings:

Format

Send to:

Choose Destination
    Biochim Biophys Acta. 2008 Feb;1780(2):75-88. Epub 2007 Nov 22.

    The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance.

    Source

    Department of Chemistry and Biochemistry, Science 246, 1600 Holloway Ave., San Francisco State University, San Francisco, CA 94132, USA. macher@sfsu.edu

    Abstract

    In 1985, we reported that a naturally occurring human antibody (anti-Gal), produced as the most abundant antibody (1% of immunoglobulins) throughout the life of all individuals, recognizes a carbohydrate epitope Galalpha1-3Galbeta1-4GlcNAc-R (the alpha-gal epitope). Since that time, an extensive literature has developed on discoveries related to the alpha-gal epitope and the anti-Gal antibody, including the barrier they form in xenotransplantation and their reciprocity in mammalian evolution. This review covers these topics and new avenues of clinical importance related to this unique antigen/antibody system (alpha-gal epitope/anti-Gal) in improving the efficacy of viral vaccines and in immunotherapy against cancer.

    PMID:
    18047841
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2271034
    Free PMC Article

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk